NX
QUANEX Posts $0.79 Adjusted EPS as Margins Widen, Repays $42M Debt
Quanex reported fiscal third-quarter net sales of $501.8 million, up 1.3%, swinging to a $26.5 million profit after last year's goodwill writedown.
Latest
NVO
NOVO NORDISK Completes Phase 3 Trial of CagriSema Against Tirzepatide
The Danish drugmaker's head-to-head Phase 3 study of CagriSema versus Eli Lilly's tirzepatide in type 2 diabetes is now listed as completed.
SNTI
SENTI BIOSCIENCES Files Amended Terms for Senior Secured Convertible Notes
An 8-K discloses a revised form of senior secured convertible note maturing November 23, 2026, repayable in cash at 200% of outstanding principal.
BSP
BENDING SPOONS Completes Acquisition of Airtable
The Milan-based app owner closed its previously announced purchase of all outstanding shares of Formagrid, the company behind Airtable, on September 4.
LND
BRASILAGRO Guides to 452,900 Tons for 2026/27 as El Niño Reshapes Crop Mix
The Brazilian farmland operator plans 165,208 hectares next season, cutting first-crop cotton 70% and dropping second-crop beans while lifting corn and pasture.
KXIN
KAIXIN Doubles Share Payout for Taohaoche Deal After 70% Stock Slide
Kaixin will issue 10 million extra Class A shares to the seller of Hongkong Taohaoche after its stock fell from above $5.00 to under $1.50.
EGAN
EGAIN Guides Fiscal 2027 Revenue Below Fiscal 2026 as Legacy Business Shrinks
eGain grew fiscal 2026 revenue 3% to $91.1 million and lifted AI customer revenue 20%, but guided fiscal 2027 sales down to $84.5-$86.0 million.
ALB
ALBEMARLE Names BHP Executive Ragnar Udd as CEO From February 2027
Kent Masters hands over the CEO role to BHP's chief commercial officer and becomes executive chairman of the lithium producer.
NCPL
NETCAPITAL Director Quits, Citing SEC Fraud Suit Against Company and Officers
A Netcapital board member resigned immediately over the SEC's August 10 civil action and demanded D&O insurance and indemnification records within 10 business days.
USAR
USA RARE EARTH Closes Serra Verde Deal After Second Merger Amendment
The 8-K reports a completed acquisition, new debt, unregistered share issuance and a board change, alongside a September 3 amendment to the Serra Verde merger agreement.
TARS
TARSUS Closes Alkeus Deal, Adding Phase 3 Stargardt Drug
Tarsus Pharmaceuticals has completed its acquisition of Alkeus, gaining worldwide rights to oral Stargardt disease candidate gildeuretinol.
NTLA
INTELLIA Lands Up to $400M Non-Dilutive Debt Facility From OrbiMed
The CRISPR company drew $75 million at closing, with $325 million more tied to milestones ahead of a planned U.S. launch of lonvo-z in hereditary angioedema.